Cutaneous disorders and HCV

Ann Med Interne (Paris) 2000 Feb;151(1):46-52
Cutaneous disorders associated with hepatitis C virus infection.
Cordel N, Chosidow O, Frances C; Service de Medecine Interne, CHU Pitie-Salpetriere, Paris.

Since the discovery of hepatitis C virus (HCV) in 1989, many cutaneous disorders have been observed in patients suffering from chronic HCV infection.

The relationship between HCV infection and cryoglobulinemia or porphyria cutanea tarda (PCT) is now clearly established, but the link between HCV and other dermatoses is still controversial.

This review of the main dermatologic disorders, directly or indirectly related to HCV infection, lead to conclude that HCV markers have to be investigated systematically in case of cryoglobulinemia, PCT or pruritus.

In other dermatologic disorders, HCV serology will be necessary only in case of risk factors for HCV infection, or presence of abnormal liver function tests.

PMID: 10761562, UI: 20224628

Advertisement

Hepatitis C Primer Home

What is Hepatitis How is Hepatitis Transmitted

Long-term Prognosis

Complications of HCV Liver Biopsy Treatment Info (Interferon, Herbal, etc) Lab Tests (PCR, Genotype,etc.) Nutrition & Alternative Info

Patient Information (Support Groups, Doctor Listing, etc) Related Webpages Transplant Info Site Search HCV Webrings Guestbook FAQ & Disclaimers

15 Tips for Managing Interferon-Ribavirin Side Effects
Finding new ways to manage the side effects of Hepatitis C combination therapy adds to a person’s likelihood of conquering the virus....

New Mexico Offers Free Hepatitis C Hotline
Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about...

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...

More Hep C articles ...